TScan Therapeutics
  • About
    • Our Company
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Partners

    About TScan

    TScan is dedicated to changing lives by discovering new cancer targets and developing safe and effective T-cell therapies for patients.

  • Technology
    • Our Approach
    • TargetScan
    • ReceptorScan
    • T-Integrate Cell Engineering
    • Publications

    Technology

    TScan’s therapeutic approach is based on the central premise that we can learn from patients who are winning their fight against cancer in order to treat those who are not.

  • Investors and Media
  • Pipeline
  • Careers
  • About
    • Our Company
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Partners
  • Technology
    • Our Approach
    • TargetScan
    • ReceptorScan
    • T-Integrate Cell Engineering
    • Publications
  • Investors and Media
  • Pipeline
  • Careers

About

Leadership

  • Management
  • Board of Directors
  • Advisory Board

Timothy Barberich

Founder of Sepracor

David Southwell

President and CEO of TScan Therapeutics

Ittai Harel

Managing General Partner with Pitango Venture Capital

Katina Dorton, J.D., M.B.A.

CFO of Nodthera

Gabriela Gruia, M.D.

Chief Development Officer at Ichnos Sciences

Stephen Biggar, M.D., Ph.D.

Partner at Baker Bros. Advisors LP

Interested in joining our team? Explore Careers

©2023 TScan Therapeutics
  • Contact
  • Privacy policy
  • Terms and conditions